DHL Commits €2 Billion to a Dedicated Pharma Cold Chain Network
A Boeing 777 freighter now runs Brussels to Cincinnati in health-logistics livery, part of an investment through 2030 across more than 30 GDP-compliant hubs.

DHL Group announced on 19 February 2026 that it is expanding its dedicated airfreight cold chain network, backed by a €2 billion strategic investment in DHL Health Logistics running through 2030. A dedicated Boeing 777 freighter now operates the Brussels to Cincinnati lane in a new health-logistics livery, giving consistent controllable capacity on one of the most critical transatlantic pharmaceutical routes.
The network spans more than 30 hubs and gateways worldwide built to Good Distribution Practice, and the infrastructure includes a deep temperature-controlled GDP-compliant facility at BRUcargo, purpose-built to reduce reliance on passive packaging and refrigerated containers. Scope covers temperature-sensitive medicines, vaccines, pharmaceutical products and cell and gene therapies, with end-to-end visibility promised across the network.
Two things in that are worth separating. Buying a dedicated aircraft for a single lane is a statement about handovers: the temperature record breaks where custody changes, and controlling the whole chain is the expensive way to stop it breaking. And a facility designed to reduce dependence on passive packaging moves risk from the box to the building — which raises rather than lowers the requirements on the monitoring underneath, because a passive shipper fails gracefully over hours while a chilled room fails on the timescale of its compressor.
For anyone integrating monitoring into this kind of infrastructure, a capital programme of this size and duration is a dated pipeline of building-scale work: mapped sensor networks, data capture validated to 21 CFR Part 11 and EU Annex 11, alarm escalation that reaches a person who can act, and integration between facility telemetry and the in-transit loggers travelling with each consignment.
The last of those is where most of these systems are weakest. A facility system and a shipment logger usually come from different vendors with different clocks, different identifiers and different retention rules, and reconciling the two into a single defensible record for one consignment is exactly the work an auditor eventually asks to see.
Source: Pharmaceutical Commerce